Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-02-26

Clinical Trial Update: Absorption of Insulin Following Subcutaneous Bolus Administration With Different Bolus Durations [Phase 1]

View source ↗

Summary

This Phase 1 study examines how insulin absorption from a subcutaneous bolus changes with different bolus durations in individuals with Type 1 Diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin (insulin)

Snippet

Sponsor: Medical University of Graz | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED